Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clini...
Q2 2026
Sep 17, 2026
Q1 2026
May 13, 2026
FY 2025
Mar 26, 2026
Q4 2025
Q2 2025
Sep 17, 2025